Dose-related effects of chronic antidepressants on neuroprotective proteins BDNF, Bcl-2 and Cu/Zn-SOD inrat hippocampus

Neuropsychopharmacology

Volumn 28, Issue 1, 2003, Pages 53-62

  Xu, Haiyun ^a   Richardson, J Steven ^a,b   Li, Xin Min ^a  

^a Neuropsychiatric Research Unit   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Antidepressants; Bcl 2; BDNF; Cu Zn SOD; Hippocampus; Immunohistochemistry

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLOHEXANOL DERIVATIVE; NEUROPROTECTIVE AGENT; PROTEIN BCL 2; SEROTONIN UPTAKE INHIBITOR; SUPEROXIDE DISMUTASE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ANIMAL; ARTICLE; DENSITOMETRY; DOSE RESPONSE; DRUG EFFECT; ENZYMOLOGY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; RAT; SPRAGUE DAWLEY RAT; WEIGHT GAIN;

AMITRIPTYLINE; ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BRAIN-DERIVED NEUROTROPHIC FACTOR; CYCLOHEXANOLS; DENSITOMETRY; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; NEUROPROTECTIVE AGENTS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN UPTAKE INHIBITORS; SUPEROXIDE DISMUTASE; WEIGHT GAIN;

EID: 0037209045     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/sj.npp.1300009     Document Type: Article

References (58)

1. Ananth C, Thameem DS, Gopalakrishnakone P, Kaur C (2001).Domoic acid-induced neuronal damage in the rat hippocampus:changes in apoptosis related genes (Bcl-2, Bax, caspase-3) andmicroglia response.J Neurosci Res66: 177-190.
2. Armitage LL, Mohapei P, Jenkins EM, Hannesson DK, Corcoran ME (1998). Dissociation between mossy fiber sprouting andrapid kindling with low-frequency stimulation of the amygdala.Brain Res781: 37-44.
3. Bernier PA, Parent A (1998a). The anti-apoptosis bcl-2 proto-oncogene is preferentially expressed in limbic structures of the primate brain.Neuroscience82: 635-640.
4. Bernier PA, Parent A (1998b). Bcl-2 protein as a marker of neuronal immaturity in postnatal primate brain.J Neurosci18:2486-2497.
5. Bodnoff SR, Suranyi-Cadotte B, Quirion R, Meaney MJ (1989). A comparison of the effects of diazepam versus several typical andatypical antidepressant drugs in an animal model of anxiety.Psychopharmacology (Berl)97: 277-279.
6. Bunney WE, Davis JM (1965). Norepinephrine in depressive reactions: A review.Arch Gen Psychiatry13: 483-494.
7. Chen DF, Schneider GE, Martinou JC, Tonegawa S (1997). Bcl-2 promotes regeneration of severed axons in mammalian CNS.Nature385: 434-439.
8. Chen G, Zeng WZ, Yuan PX, Huang LD, Jiang YM, Zhao ZHet al(1999). The mood-stabilizing agents lithium and valproaterobustly increase the levels of the neuroprotective protein bcl-2 in the CNS.J Neurochem72: 879-882.
9. Dowlatshahi D, MacQueen GM, Wang JF, Young LT (1998). Increased temporal cortex CREB concentrations and antidepressant treatment in major depression.Lancet352: 1754-1755.
10. Duman RS, Heninger GR, Nestler EJ (1997). A molecular and cellular theory of depression.Arch Gen Psychiatry54: 597-606.
11. Duman RS, Malberg J, Thome J (1999). Neural plasticity to stress and antidepressant treatment.Biol Psychiatry46: 1181-1191.
12. Ferrer I, Lopez E, Blanco R, Rivera R, Ballabriga J, Pozas E, Marti E (1998). Bcl-2, Bax, and Bcl-x expression in the CA1 area of thehippocampus following transient forebrain ischemia in the adultgerbil.Exp Brain Res121: 167-173.
13. Ferretti C, Blengio M, Gamalero SR, Ghi P (1995). Biochemical and behavior changes induced by acute stress in a chronic variatestress model of depression: the effects of amitriptyline.Eur JPharmacol280: 19-26.
14. Gombos Z, Spiller A, Cottrell GA, Racine RJ, Burnham WM (1999).Mossy fiber sprouting induced by repeated electroconvulsiveshock seizures.Brain Res844: 28-33.
15. Goodwin FK, Ebert MH, Bunney WE (1972). Mental effects of reserpine in man: A review. In: Shader RI (ed).PsychiatricComplications of Medical Drugs.Raven: New York, pp 73-101.
16. Greenlund LJS, Deckwerth TL, Johnson EM (1995). Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygenspecies in programmed cell death.Neuron14: 303-316.
17. Gur E, Dremencov E, Lerer B, Newman ME (1999). Venlafaxine: acute and chronic effects on 5-hydroxytryptamine levels in ratbrain in vivo.Eur J Pharmacol372: 17-24.
18. Gur E, Dremencov E, Van De Kar LD, Lerer B, Newman ME (2002). Effects of chronically administered venlafaxine on 5-HT receptoractivity in rat hippocampus and hypothalamus.Eur J Pharmacol436: 57-65.
19. Hara A, Hirose Y, Wang A, Yoshimi N, Tanaka T, Mori H (1996). Localization of Bax and Bcl-2 proteins, regulators of pro-grammed cell death, in the human central nervous system.Virchows Arch429: 249-253.
20. Henshall DC, Skradski SL, Lan IQ, Ren T, Simon RP (2001). Increased Bcl-w expression following focally evoked limbicseizures in the rat.NeurosciLett305: 153-156.
21. Hirschfeld RM (2000). History and evolution of the monoamine hypothesis of depression.J Clin Psychiatry61(Suppl 6) 4-6.
22. Imaizumi S, Woolworth V, Fishman RA, Chan PH (1990). Liposome-entrapped super-oxide dismutase reduces cerebralinfarction in cerebral ischemia in rats.Stroke21: 1312-1317.
23. Jacobson MD, Raff M (1995). Programmed cell death and Bcl-2 protection in very low oxygen.Nature374: 814-816.
24. Jesberger JA, Richardson JS (1985). Neurochemical aspects of depression: The past and the future?Int J Neurosci27: 19-47.
25. Kaufmann JA, Bickford PC, Taglialatela G (2001). Oxidative-stress-dependent up-regulation of Bcl-2 expression in the central nervous system of aged Fisher-344 rats.J Neurochem76: 1099-1108.
26. Kim HC, Bing G, Jhoo WK, Ko KH, Kim WK, Suh JHet al(2000). Changes of hippocampal Cu/Zn-superoxide dismutase afterkainate treatment in the rat.Brain Res853: 215-226.
27. Lamont SR, Paulls A, Stewart CA (2001). Repeated electroconvul-sive stimulation, but not antidepressant drugs, induces mossy fiber sprouting in the rat hippocampus.Brain Res893: 53-58.
28. Li XM, Juorio AV, Qi J, Boulton AA (1998). L-deprenyl potentiates NGF-induced changes in superoxide dismutase mRNA in PC12cells.J Neurosci Res53: 235-238.
29. Li XM, Chlan-Fourney J, Juorio AV, Bennett VL, Shrikhande S, Bowen RC (2000). Antidepressants upregulate messenger RNAlevels of the neuroprotective enzyme superoxide dismutase(SOD1).J Psychiatry Neurosci25: 43-47.
30. Malberg J, Eisch A, Nestler E, Duman RS (2000). Chronic antidepressant treatment increases neurogenesis in adult rathippocampus.J Neurosci20: 9104-9110.
31. Malatynska E, Leon ID, Allen D, Yamamura HI (1995).Effects of amitriptyline on GABA-stimulated36Cl uptake in relation to abehavioral model of depression.Brain Res Bull37: 53-59.
32. Manji HK, Moore GJ, Chen G (2000). Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: A role for Neurotrophic and neuroprotective effects in manic depressive illness.J Clin Psychiatry6(Suppl 9) 82-96.
33. McGrath C, Norman TR (1998).The effect of venlafaxine treatment on the behavioral and neurochemical changes in theolfactory bulbectomised rat.Psychopharmacology (Berl)136:394-401.
34. Merry DE, Korsmeyer SJ (1997).Bcl-2 gene family in the nervous system.Annu Rev Neurosci20: 245-267.
35. Nakamura M, Raghupathi R, Merry DE, Scherbel U, Saatman KE, McIntosh TK (1999). Overexpression of Bcl-2 is neuroprotectiveafter experimental brain injury in transgenic mice.J CompNeurol412: 681-692.
36. Nemeroff CB (1998). Psychopharmacology of affective disorders in the 21st century.Biol Psychiatry44: 517-525.
37. Nibuya M, Morinobu S, Duman RS (1995). Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsiveseizure and antidepressant drug treatments.J Neurosci15: 7539-7547.
38. Nibuya M, Nestler EJ, Duman RS (1996). Chronic antidepressant administration increases the expression of cAMP responseelement binding protein (CREB) in the rat hippocampus.JNeurosci16: 2365-2372.
39. Nishiyama K, Murayama S, Shimizu J, Ohya Y, Kwak S, Asayama Ket al(1995). Cu/Zn superoxide dismutase-like immunoreactivityis present in Lewy bodies from Parkinson disease: A light andelectron microscopic immunocytochemical study.ActaNeuro-pathol (Berl)89: 471-474.
40. Niwa M, Hara A, Iwai T, Sassa T, Mori H, Uematsu T (1997). Expression of Bax and Bcl-2 protein in the gerbil hippocampusfollowing transient forebrain ischemia and its modification byphencyclidine.Neurol Res19: 629-633.
41. Phillips HS, Hains JM, Laramee GR, Rosenthal A, Winslow JW (1990).Widespread expression of BDNF but not NT-3 by targetareas of basal forebrain cholinergic neurons.Science250: 290-294.
42. Qiao X, Suri C, Knusel B, Noebels JL (2001). Absence of hippocampal mossy fiber sprouting in transgenic mice overexpressing brain-derived neurotrophic factor.J Neurosci Res64:268-276.
43. Reid IC, Stewart CA (2001). How antidepressants work.Br J Psychiatry178: 299-303.
44. Richardson JS, Jesberger JA (1986).Models for the experimental analysis of depression.ActaPsychiatrBelg86: 733-747.
45. Richardson JS, Tiong AK (1999).Amygdaloid and hippocampal ß-adrenoceptors in the olfactory bulbectomy syndrome: Effects ofdesipramine.Ann NY AcadSci877: 764-768.
46. Saggu H, Cooksey J, Dexter D, Wells FR, Lees A, Jenner P, Marsden CD (1989). A selective increase in particulate superoxidedismutase activity in parkinsoniansubstantianigra.J Neuro-chem53: 692-697.
47. Schildkraut JJ (1965). The catecholamine hypothesis of affective disorders: A review of supportive evidence.Am J Psychiatry122:509-522.
48. Shirayama Y, Chen ACH, Nakagawa S, Russell DS, Duman RS (2002). Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression.J Neurosci22:3251-3261.
49. Siuciak JA, Lewis DR, Wiegand SJ, Lindsay RM (1997). Anti-depressant-like effect of brain-derived neurotrophic factor (BDNF).PharmacolBiochemBehav56: 131-137.
50. Sofroniew MF, Couture R, Cuello AC (1983). Immunocytochem-istry: Preparation of antibodies and staining specificity. In: Bjorklund A, Hokfelt T (eds).Methods in Chemical Neuroanat-omy.Elsevier: New York, pp 210-227.
51. Stockert M, Serra J, Robertis ED (1988). Effect of olfactory bulbectomy and chronic amitriptyline treatment in rats:3H-imipramine binding and behavioral analysis by swimming andopen field tests.PharmacolBiochemBehav29: 681-686.
52. Takata K, Kitamura Y, Kakimura J, Kohno Y, Taniguchi T (2000). Increase of Bcl-2 protein in neuronal dendritic processes ofcerebral cortex and hippocampus by the antiparkinsonian drugs, talipexole and pramipexole.Brain Res872: 236-241.
53. Thome J, Sakai N, Shin K, Steffen C, Zhang YJ, Impey S, Storm D, Duman RS (2000). cAMP response element-mediated genetranscription is upregulated by chronic antidepressant treatment.J Neurosci20: 4030-4036.
54. Uyama O, Matsuyama T, Michishita H, Nakamura H, Sugita M (1992).Protective effects of human recombinant superoxidedismutase on transient ischemic injury of CA1 neurons ingerbils.Stroke23: 75-81.
55. Vaidya VA, Duman RS (2001). Depression: Emerging insights from neurobiology.Br Med Bull57: 61-79.
56. Vetulani J, Sulser F (1975). Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain.Nature257: 495-496.
57. Watanabe Y, Gould E, Daniels DC, Cameron H, McEwen BS (1992). Tianeptine attenuates stress-induced morphological changes inthe hippocampus.Eur J Pharmacol222: 157-162.
58. Xu H, Qing H, Lu W, Keegan D, Richardson JS, Chlan-Fourney J, Li XM (2002).Quetiapine attenuates the immobilization stress-induced decrease of brain-derived neurotrophic factor expression in rat hippocampus.NeurosciLett321: 65-68.